Stocks Squeeze out Small Gains

But Merck kept the Dow in check after dropping a key drug trial. Next week brings a heavy dose of economic news

Stocks eked out small gains on Friday on upbeat corporate profit news. But the blue-chip Dow average was kept in check by Merck (MRK ) after the Big Pharma stalwart announced it was dropping a key drug trial.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.